Dupilumab Provides Sustained Control of Eosinophilic Otitis Media Through Suppression of Type 2 Inflammation: A Long-Term Cohort Study With Molecular Profiling of Middle Ear Effusion
{{output}}
Aim: To evaluate the long-term clinical efficacy of dupilumab and elucidate its mechanism of action by analyzing local and systemic cytokine profiles in patients with severe eosinophilic otitis media (EOM). ... ...
